New substituted benzimidazole derivatives: a patent review (2010 – 2012)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.9, 2013-09, pp. : 1157-1179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substituted oxadiazoles: a patent review (2010 – 2012)

By Zarghi Afshin Hajimahdi Zahra

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 9, 2013-09 ,pp. : 1209-1232

Informa Healthcare

Access to resources Recommend Favorite

BACE2 as a new diabetes target: a patent review (2010 – 2012)

By Southan Christopher

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 649-663

Informa Healthcare

Access to resources Recommend Favorite

Resveratrol derivatives: a patent review (2009 – 2012)

By Pezzuto John M Kondratyuk Tamara P Ogas Talysa

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1529-1546

Informa Healthcare

Access to resources Recommend Favorite

Berberine and its derivatives: a patent review (2009 – 2012)

By Singh Inder Pal Mahajan Shivani

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 215-231

Informa Healthcare

Access to resources Recommend Favorite

Acridine derivatives: a patent review (2009 –– 2010)

By Kaur Jatinder Singh Palwinder

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 4, 2011-04 ,pp. : 437-454

Informa Healthcare

Access to resources Recommend Favorite